动脉粥样硬化及支架置入后炎症因子的变化与干预治疗

动脉粥样硬化为一多因素疾病,慢性炎症介导其发生、发展的全过程.炎症过程的一些因子,如C-反应蛋白,白细胞介素6,,细胞黏附分子,肿瘤坏死因子a-等,不但参与动脉粥样硬化相关疾病的发病过程.而且还可预示心血管事件发生的危险.炎症因子的水平对急性冠状动脉综合征等动脉粥样硬化性疾病的诊断、治疗和预后判断具有重要的价值.近年来的研究发现,在心脏支架置入后也存在着明显的炎症反应,这种炎症反应在内膜的重塑过程中、尤其是支架内再狭窄中起很重要的作用.因此,探讨炎症过程的分子机制及其病理变化,研究药物对炎症反应的防治作用,将成为预防和治疗动脉粥样硬化及其并发症的新靶点.

Inflammatory factor alteration and intervention for atherosclerosis after stenting

Atherosclerosis is a multifactorial disease and mediated by chronic inflammation from initiation to progression. Inflammatory factors of this process, such as C-reactive protein, interleukin-6, cell adhesion molecules and tumor necrosis factor-a, not only involve in atherosclerosis-related disease process, but also indicate the risk of cardiovascular events. Inflammatory factors level plays a significant role in diagnosis, treatment and prognosis of atherosclerosis-related disease, such as acute coronary syndrome. Recent studies have shown that there is a marked inflammatory response after stenting, which plays an important role in the vascular remodeling process, especially in-stent restenosis. Therefore, it is necessary to explore the molecular mechanism and pathological changes in the process of inflammation and to study prevention and treatment of the inflammation. We believe that inflammatory processes will be new targets of therapy in preventing or treating atherosclerosis and its complications.